Respiratory Disease Testing Market - Snapshot

The global respiratory disease testing market is likely to witness high growth due to rapid spread of a respiratory disease, coronavirus, disease across the world. With an exponential growth in the number of coronavirus infected person across the globe, the need for testing to detect the presence SARS-COVID-19 virus has accelerated.

The function of a respiratory tract comprises fetching oxygen from the atmosphere in the lungs, transferring it to the blood, and then to exhale CO2.. Breathing is generally habitual and is regulated by the respiratory center located at the brain’s base. Besides, the respiratory system also assists in the removal or toxic waste, temperature control, and stabilization of blood-alkaline balance (pH). Respiratory diseases restrict the usual operation of the system and are generally caused by inhaling toxic agents, unhealthy lifestyle, and smoking. As such, the significance of the respiratory system is likely to encourage growth of the global respiratory disease testing market.

Alarming Rise in the Level of Pollutants to Drive the Demand for these Tests

An alarming rise in the level of toxic particles in the air together with the emission of hazardous gases from various sources is accelerating the occurrences of various lung diseases. Increased prevalence of such as chronic obstruction pulmonary diseases (COPD) and other diseases of the respiratory system could be observed around the world. This factor is likely to bolster the growth of the global respiratory disease testing market in the years to come.

In the spread of various types of infections such as the ones acquired during hospital stay and tuberculosis, these tests are the initial tests to determine the presence of virus. Respiratory measurements are also called respirometers and comprise the following

  • Spirometers
  • Pulse Oximeters
  • Capnographs
  • Peak Flowmeters

Apart from infections, genetic factors also play an important role in influencing the global respiratory disease testing market over the period of assessment.

Global Respiratory Disease Testing Market: Snapshot

The global respiratory disease testing market is anticipated to grow at a stupendous rate due to rise in prevalence of respiratory diseases all across the world. According to World Health Organization there were 251mn of chronic obstructive pulmonary disease (COPD) across the world in 2016 and it is predicted that nearly 3.17mn of deaths were caused due to the diseases which is nearly 5% of deaths globally for 2015. These mind blowing results have propelled manufacturers to tune up their production rate in order to meet the demand from the healthcare industry.

The global respiratory disease testing market is anticipated to expand at CAFR of 3.4% during the forecast period 2014 – 2022. The market was valued at US$2326.5 mn and is like to rise to US$3143.3 mn by the end of the assessed period.

Availability of Basic Respiratory Devices Makes Hospitals Top End User

On the basis of anatomical features the market is segregated into lower respiratory tract and upper respiratory tract. The upper respiratory tract consists of larynx, nasal passages, and pharynx, whereas the lower respiratory tract includes lungs, bronchi, and trachea. Diseases such as COCD, asthma, pneumonia, and cystic fibrosis are the main reason behind the use of respiratory disease testing. Rise in case of such diseases have directly made a positive impact on the growth of the market. However, it has been noticed that low adoption rate of digital radiography and portable spirometers are likely to deter the growth of the respiratory disease testing market during the projected period.

On the basis of type of test the market is segregated into spirometry, blood gas test, peak flow test, long volume test, imaging tests, and others. Amongst the pack, imagining test segment held a significant share of the market owing to the rise in demand for X-ray which is used for checking fracture in the bones. Apart from these, the tests is considered to be first-line off diagnostic tests for respiratory diseases.

On the basis of end-user, the market can be bifurcated into clinical laboratories, physician offices, and hospitals. Hospitals accounted for the largest share in the market due to its presence in the most developed as well as underdeveloped parts. This particular segment lead the market as most of the devices are present in the hospitals. Apart from that, doctors these days opt for in house diagnostic test over laboratories.

North America Dominates Market due to Uptake of Portable Devices

The global respiratory disease testing market on the basis of geography is spread across North America, Asia Pacific, Europe, and Latin America, MEA. Recently, North America held the largest market share attributing to the rise in prevalence of respiratory diseases, surge in demand for home healthcare services accompanied with increase in popularity of portable devices. However Asia Pacific is anticipated to become the fastest growing market due to the presence of emerging economies country such as Indonesia, China, India, Singapore, Thailand, Korea, and Malaysia. Untapped opportunities, rising awareness about the diagnostic procedures, and enhanced healthcare infrastructure is anticipated to drive the market. Apart from these, incessant rise in population along with rise in disposable income in the region is favoring the growth of the market.

Some of the major players in the market are CareFusion Corporation, GE Healthcare, Nihon Kohden Corporation, and ndd Medical Technologies, Inc. (EasyOne Pro LAB),

COVID-19 Pandemic to Increase the Growth Opportunities across the Respiratory Disease Testing Market

The rapid spread of respiratory diseases among a large chunk of the global populace around the world will bring good growth opportunities for the respiratory disease testing market during the forecast period of 2014-2022. Pollution levels around the world have risen considerably over the years. The growing pollution levels will have a positive impact on the growth of the respiratory disease testing market.

  • The testing methods used for treating a variety of diseases related to the respiratory tract come under respiratory disease testing. The frequent rise in the incidence of respiratory diseases will bring good growth opportunities for the respiratory disease testing market. The advantages attached will bring promising growth.
  • The release of harmful gases into the body and the increasing spread of infections related to the respiratory tract have a great impact on the growth of the respiratory disease testing market. Infections such as tuberculosis and hospital-acquired infections also play a vital role in increasing the growth prospects of the respiratory disease testing market.
  • Research and development activities are crucial for the growth of the respiratory disease testing market. The players in the respiratory disease testing market invest in these activities for increasing their revenues. These activities ultimately boost the growth prospects of the respiratory disease testing market.
  • Strategic collaborations form the foundation of the growth of the respiratory disease testing market. The players indulge in these activities for expanding their influence across the respiratory disease testing market. These factors eventually help in increasing the growth rate of the respiratory disease testing market.
  • The COVID-19 pandemic has a positive effect on the respiratory disease testing market. COVID-19 causes respiratory problems. These problems have to be diagnosed and cured at an early stage to prevent further damage. The rising number of COVID-19 patients will serve as a profitable growth factor for the respiratory disease testing market.

The global respiratory disease testing market is witnessing a surge in market valuation in the recent years. The rising frequency of respiratory diseases, triggered by the rapid increase in the global geriatric population, has given an impetus to the market in the past. This trend is also expected to boost the worldwide market for respiratory disease testing during the period from 2014 to 2022 significantly. 

The global market for respiratory disease testing is broadly analyzed on the basis of the types of tests performed and the end-use industries. Spirometry tests, imaging tests, peak flow tests, lung volume tests, and blood gas tests are the major test segments of this market while hospitals, clinical laboratories, and physician offices are the primary end users.

Apart from this, the worldwide respiratory disease testing market is also evaluated on the basis of its regional distribution into North America, Latin America, Europe, Asia Pacific, the Middle East and North Africa, and the Rest of the World. The U.S. and Canada drive the respiratory disease testing market in North America. Brazil, Mexico, and the Rest of LATAM lead it in Latin America. The U.K., Germany, and the Rest of Europe are the main markets for respiratory disease testing in Europe. Asia Pacific is driven by the market in China, Japan, and Rest of APAC and the Middle East and North Africa is led by the UAE, Saudi Arabia, and the Rest of MENA.

This research report provides a comprehensive overview of the global market for respiratory disease testing and helps market participants in making significant strategies and crucial decisions for the further development of their businesses.

Overview of the Respiratory Disease Testing Market 

The global market for respiratory disease testing has been continuously showing an impressive rise. In 2013, it stood at a US$2.3 bn. Analysts estimate it to expand at a CAGR of 3.40% during the period from 2014 to 2022 and reach a value of US$3.1 bn by the end of the forecast period.

Among the tests markets, the imaging tests segment led the worldwide market for respiratory disease testing in 2013 owing to the extensive uptake of imaging measures, specifically X-ray. However, the market for spirometry tests is expected to report the highest CAGR over the forecast period. The efficiency of these tests, enhancing the precision in results are projected to boost this market segment in the coming years.

Among end users, the hospital segment emerged as the market leader in 2013 and is likely to maintain its position in the near future.

Among regional markets, North America led the global respiratory disease testing market in 2013. On the other hand, the Asia Pacific respiratory disease testing market is anticipated to exhibit the highest CAGR over the forecast period.

The worldwide market for respiratory disease testing exhibits a positive growth. However, the low adoption rate of advanced spirometers as well as the digital radiography systems is likely to hamper the growth of this market over the next few years.

Companies mentioned in the research report 

CareFusion Corp., COSMED, Carestream Health Inc., Futuremed America Inc., MGC Diagnostics Corp., GE Healthcare, ndd Medical Technologies Inc., Perkin Elmer Inc., NIHON KOHDEN Corp., Philips Healthcare, Siemens Healthcare, SDI Diagnostics, and Smiths Medical are the major players operating in the global respiratory disease testing market.

Key segments of the Respiratory Disease Testing Market

By Test

  • Imaging Tests
  • Spirometry Tests
  • Peak Flow Tests
  • Blood Gas Tests
  • Lung Volume Tests
  • Other Tests

By End User

  • Hospitals
  • Physician Offices
  • Clinical Laboratories

Major regions analyzed under this research report are: 

  • Europe
  • North America 
  • Asia Pacific 
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Secondary Research

      1.3.2 Primary Research

      1.3.3 Models

      1.3.4 Assumptions

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022)

2.2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)

2.3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 and 2022 (Value %)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Value Chain Analysis

3.3 Market Drivers

      3.3.1 Increasing prevalence of respiratory diseases

      3.3.2 Growing geriatric population propels the uptake of respiratory disease testing products

      3.3.3 Technological advancements boost demand for respiratory disease testing products

3.4 Restraints

      3.4.1 Low adoption rate of digital radiography systems and advanced spirometers

3.5 Opportunities

      3.5.1 Capitalizing on the potential presented by emerging markets in Asia-Pacific

3.6 Regulatory Framework

3.7 Porter’s Five Forces Analysis: Global Respiratory Disease Testing Market

      3.7.1 Bargaining power of suppliers

      3.7.2 Bargaining power of buyers

      3.7.3 Threat of substitutes      

      3.7.4 Threat of new entrants

      3.7.5 Competitive rivalry

3.8 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography

      3.9.1 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)

 

Chapter 4 Global Respiratory Disease Testing Market, by Tests

4.1 Overview

      4.1.1 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 – 2022 (USD Million)

4.2 Imaging Tests

      4.2.1 Global Imaging Test Market Revenue, 2012 – 2022 (USD Million)

4.3 Spirometry

      4.3.1 Global Spirometry Test Market Revenue, 2012 – 2022 (USD Million)

4.4 Peak Flow Test

      4.4.1 Global Peak Flow Test Market Revenue, 2012 – 2022 (USD Million)

4.5 Blood Gas Test

      4.5.1 Global Blood Gas Test Market Revenue, 2012 – 2022 (USD Million)

4.6 Lung Volume Test

      4.6.1 Global Lung Volume Test Market Revenue, 2012 – 2022 (USD Million)

4.7 Other Tests (Exercise, Gas transfer, Bronchoscopy, Thoracoscopy, etc.)

      4.7.1 Global Other Tests Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 5 Global Respiratory Disease Testing Market, by End-User

5.1 Overview      

      5.1.1 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 – 2022 (USD Million)

5.2 Hospitals

      5.2.1 Global Hospitals End-User Market Revenue, 2012 – 2022 (USD Million)

5.3 Physician Offices

      5.3.1 Global Physician Offices End-User Market Revenue, 2012 – 2022 (USD Million)

5.4 Clinical Laboratories

      5.4.1 Global Clinical Laboratories End-User Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 6 Global Respiratory Disease Testing Market, by Geography

6.1 Overview

      6.1.1 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

6.2 North America

      6.2.1 North America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.2.2 U.S.

              6.2.2.1 U.S. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.2.3 Canada

              6.2.3.1 Canada Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.3 Europe

      6.3.1 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.3.2 U.K.

             6.3.2.1 U.K. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.3.3 Germany

             6.3.3.1 Germany Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.3.4 Rest of Europe

             6.3.4.1 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.4 Asia Pacific

      6.4.1 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.4.2 Japan

              6.4.2.1 Japan Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.4.3 China

              6.4.3.1 China Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.4.4 Rest of Asia Pacific

              6.4.4.1 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.5 Latin America

      6.5.1 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)      

      6.5.2 Brazil

              6.5.2.1 Brazil Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.5.3 Mexico

              6.5.3.1 Mexico Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.5.4 Rest of Latin America 

              6.5.4.1 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.6 Middle East North Africa (MENA)

      6.6.1 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

      6.6.2 Saudi Arabia

              6.6.2.1 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.6.3 UAE

             6.6.3.1 UAE Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

      6.6.4 Rest of MENA

             6.6.4.1 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

6.7 Rest of the World

      6.7.1 Rest of the World Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

 

Chapter 7 Recommendations

7.1 Market Strategy for Success

      7.1.1 Mergers and acquisitions for market expansion

      7.1.2 Emphasize on increasing affordability of modern imaging systems

      7.1.3 Investing in emerging markets

 

Chapter 8 Company Profiles

8.1 CareFusion Corporation

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 Carestream Health, Inc.

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 COSMED

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 Futuremed America, Inc.

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

8.5 GE Healthcare

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 MGC Diagnostics Corporation

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 ndd Medical Technologies, Inc.

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 NIHON KOHDEN CORPORATION

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Perkin Elmer, Inc.

      8.9.1 Company Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

8.10 Philips Healthcare

      8.10.1 Company Overview

      8.10.2 Financial Overview

      8.10.3 Product Portfolio

      8.10.4 Business Strategies

      8.10.5 Recent Developments

8.11 SDI Diagnostics

      8.11.1 Company Overview

      8.11.2 Financial Overview

      8.11.3 Product Portfolio

      8.11.4 Business Strategies

8.12 Siemens Healthcare

      8.12.1 Company Overview

      8.12.2 Financial Overview

      8.12.3 Product Portfolio

      8.12.4 Business Strategies

      8.12.5 Recent Developments

8.13 Smiths Medical

      8.13.1 Company Overview

      8.13.2 Financial Overview

      8.13.3 Product Portfolio

      8.13.4 Business Strategies

      8.13.5 Recent Developments

List of Tables

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022)

TABLE 3 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 – 2022 (USD Million)

TABLE 4 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 – 2022 (USD Million)

TABLE 5 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 6 North America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 7 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 8 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 9 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 10 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million)

List of Figures

FIG. 1 Respiratory Disease Testing : Market Segmentation

FIG. 2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 & 2022 (Value %)

FIG. 4 Value Chain Analysis of the Respiratory Disease Testing Market

FIG. 5 Porter’s Five Forces Analysis: Global Respiratory Disease Testing Market

FIG. 6 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 Value (%)

FIG. 7 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)

FIG. 8 Global Imaging Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 9 Global Spirometry Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 10 Global Peak Flow Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Global Blood Gas Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 12 Global Lung Volume Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Other Tests Market Revenue, 2012 – 2022 (USD Million)

FIG. 14 Global Hospitals End-User Market Revenue, 2012 – 2022 (USD Million)

FIG. 15 Global Physician Offices End-User Market Revenue, 2012 – 2022 (USD Million)

FIG. 16 Global Clinical laboratories End-User Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 U.S. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 18 Canada Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 19 U.K. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 20 Germany Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 22 Japan Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 China Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 24 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 Brazil Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 26 Mexico Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 27 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 28 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 29 UAE Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 30 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 31 Rest of the World Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 32 CareFusion Corporation: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 33 Carestream Health, Inc.: Annual Revenue,  2011 – 2013 (USD Million)

FIG. 34 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 35 MGC Diagnostic Corporation: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 36 NIHON KOHDEN CORPORATION: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 37 PerkinElmer Inc.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 38 Philips Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 40 Smiths Medical: Annual Revenue, 2011 – 2013 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Respiratory Disease Testing Market